期刊文献+

射频消融术对血栓前状态的影响及其拉西地平防治的观察 被引量:2

Effect of radiofrequency ablation on Prethrombotic state and prophylactic therapy of Lacidipine
原文传递
导出
摘要 目的探讨射频消融术(RFCA)对血栓前状态的影响及其拉西地平的防治效果。方法采用双抗体夹心酶联免疫吸附法(ELISA)、发色底物法和Born比浊法,观察60例患者RFCA术前、术后血浆中血管性血友病因子(vWF)、可溶性P-选择素(sP-selection)、D-二聚体(DD)、纤溶酶原激活物抑制物-1(PAI-1)和血小板聚集率(PAG)的变化,并观察拉西地平的干预效果。结果对照组vWF、sP-selection、D-Dimer、PAI-1和PAG在RFCA术后明显升高,其差异有统计学意义(P<0.05);采用拉西地平的患者术后以上指标较术前也有所增高,但差异无统计学意义(P>0.05)。结论射频消融术可促进血栓前状态的形成,拉西地平有预防作用。 Objectives To investigate the influence of radiofrequency catheter ablation(RFCA) on Prethrombotic State (PTS) and evaluate the effect of prophylactic therapy of Lacidipine. Methods With enzyme linked immunosorbent assay,chromogenic substances assay and furbidimetry assay, sixty consecutive patients were divided randomly into two groups:the control group (30 cases)treated with no drug and the treated group(30 cases)treated with Lacidipine. The levels of Von Willebrand's factor( vWF), soluble P-selection,D-Dimer,plasminogen activator inhibitor( PAI-1 )and maximum platelet aggregation rate( PAG- max)were measured before and immediately after RFCA. Results In control group,the plasma levels of vWF,sP-selection,D-Dimer,PAI -1 and PAGmax were increased significantly immediately after RFCA as compared with those before RFCA. In treated group,the levels of those markers were also increased slightly, but there were no statistical significance. Conclusions It suggests that PTS may be introduced by RFCA, and prophylactic therapy of lacidipine may prevent it. Mornitoring the plasma levels of those markers of PTS is valuable in guiding the administration of anticoagulative drugs and prophylaxis of thromboembolic disease.
出处 《临床内科杂志》 CAS 2008年第9期609-610,共2页 Journal of Clinical Internal Medicine
关键词 射频消融术 血栓前状态 拉西地平 Radiofrequency catheter ablation Prethrombotic state Lacidipine
  • 相关文献

参考文献3

  • 1Sasano T, Hirao K, Yano K, et al. Delayed thrombogenesis following radiofrequency catheter ablation. Circ J,2002,66:671-676.
  • 2李莉,邓晓蕴,尚晓明,姜玉如.射频消融对凝血状态影响的观察[J].中华心律失常学杂志,2002,6(5):273-275. 被引量:10
  • 3Chou TC, Li CY. Inhibitory mechanisms of dantrolene on platelet aggregation. Thromb Res,1999 ,96 :299-307.

二级参考文献10

  • 1Tanaka M, Suzuki A. Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers.Thromb Res, 1994, 76:289-298.
  • 2Stenberg PE, Mcever RP, Shuman MA, et al. A platelet alpha-granule membrane protain (GMP-140) is expressed on the plasma after activation. J Cell Biology,1985, 101:880.
  • 3Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol, 1995, 90:244-248.
  • 4Hindricks G. The Multicentre European Radiofreqency Survey (MERES):complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the working group on arrhythmias of the European Society of Cardiology [see conments]. Eur Heart J, 1993. 14:1644-1653.
  • 5Thakur PK, Klein GJ, Yee R, et al. Embolic complications after radiofrequency catheter ablation. Am J Cardiol,1994, 74:278-279.
  • 6Kunze KP, Hayen B, Geiger M. Ambulatory catheter ablation. Indications, results and risks. Herz, 1998, 23:135-140.
  • 7Thakur PK, Klein GJ, Yee R. Radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome.CMAJ, 1994, 151:771-776.
  • 8Manolis AS, Vassilikos V, Maounis TN, et al. Pretreatment with aspirin and ticlopidine confers lower thrombogenic potential of radiofrequency catheter ablation. Am J Cardiol, 1997, 79:496-497.
  • 9Dunlop LC, Skinner MP, Bendall LJ, et al. Characterization of GMP-140 (P-selection) as a circulating plasma protein. J Exp Med, 1992, 175:1147-1150.
  • 10Boisclair MD, Ireland H, Lane DA. Assessment of hypercoagulable states by measurement of activation fragmentsandpeptides. Blood Rev, 1990, 4:25-40.

共引文献9

同被引文献31

  • 1陈国锋,陈君柱,郑良荣,陶谦明,王利宏.射频消融对循环活化血小板的影响及噻氯匹定的作用[J].浙江临床医学,2005,7(12):1281-1282. 被引量:1
  • 2周京敏,刘少稳,聂振宁,林佳雄,吴鸿宜,周俊,蔡乃绳,葛均波.持续性与阵发性心房颤动导管射频消融肺静脉电隔离的抗凝治疗[J].中国心脏起搏与心电生理杂志,2007,21(2):116-118. 被引量:5
  • 3孙泽刚,侯子龙,王涛,徐玉鹏,王凤云.氯吡格雷对射频导管消融术血栓前状态的临床干预[J].山东医药,2007,47(25):52-53. 被引量:2
  • 4Santangeli P, Di Biase L, Mohanty P. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes [J]. J Cardiovasc Eleetrophysiol, 2012, 23(7): 687-693.
  • 5Takahashi A, Kuwahara T, Takahashi Y. Complications in the catheter ablation of atrial fibrillation: incidence and management [J]. Circ J, 2009, 73(2): 221-226.
  • 6Scherr D, Dalal D, Chilukuri K, et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation [J]. J Cardiovasc Electrophysiol, 2009, 20(4): 379-384.
  • 7Maleki K, Mohammadi R, Hart D, et al. Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention[J]. J Cardiovasc Electrophysiol, 2005, 16(6): 561-565.
  • 8Wazni OM, Rossillo A, Marrouche NF, et al. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulatiou regimens and impotance of intracardiac echo imaging [J]. J Cardiovasc Electmphysiol, 2005, 16(6): 576-581.
  • 9Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study[J]. J Am Coil Cardiol, 2003, 42(2): 185-197.
  • 10Parizek P, Haman L, Pleskot M, et al. Hemostatic changes before andduring electrophysiologic study and radiofrequency catheter ablation [J]. hat J Hematol, 2011, 93(4): 452-457.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部